MedTech Spectrum

Article Name China

Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray

The Company has acquired the rights to develop, manufacture, and commercialise CARDAMYST (etripamil) nasal spray in Greater China

24th March, 2026

Everest Medicines Launches VELSIPITY in Mainland China

VELSIPITY(R) was approved for marketing by China’s National Medical Products Administration (NMPA) in February this year

13th March, 2026

Fangzhou and Youcare Pharmaceutical Group Form Alliance to Advance AI-Driven Chronic Care Services

The agreement outlines a joint commitment to applying AI across various chronic care scenarios and upgrading full-lifecycle health management solutions

02nd March, 2026

Scaling the WHO Screen-and-Treat Model across China’s Tiered Healthcare System

In this evolving landscape, PHASE Scientific’s exclusive partnership with Liger Medical signals a strategic shift toward portable, community-deployable cervical care solutions

12th February, 2026

Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults

The approval was based on results from the Asian multicenter Phase 3 ENLIGHT UC study (ES101002) and the global ELEVATE UC Phase 3 program (ELEVATE UC 52 and ELEVATE UC 12)

09th February, 2026

Lishan Biotech Bets on Microbiome Immunotherapy BMC128

BMC128 was developed by Biomica, Evogene’s subsidiary, and is currently completing a Phase 1 clinical study, showing promising early clinical results

06th February, 2026

PHASE Scientific Expands Cervical Health Portfolio with China Distributorship of Liger Medical’s Portable Cervical Treatment

This partnership with Liger Medical reflects our commitment to bringing leading global innovation into China’s healthcare system

05th February, 2026

ZEISS announces NMPA approval in China for powerful ophthalmic microscopes, enhancing surgical visualisation

The ZEISS ARTEVO 750 ophthalmic microscope is another breakthrough in ZEISS's ophthalmic surgical microscope family that made its Chinese debut at the 2025 China International Import Expo (CIIE)

03rd February, 2026

Zylox-Tonbridge to Acquire Germany’s Optimed in Global Expansion Push

Builds an integrated global commercialisation platform to accelerate Zylox-Tonbridge's adoption of innovative vascular solutions worldwide

16th January, 2026

WORK Medical Grants East China Distribution Rights for AI-Automated Blood Cell Morphology Analyzer

The collaboration is expected to accelerate market access and drive large-scale commercialisation of the new product

30th December, 2025

Everest Medicines Announces Commercialisation Service Agreement and License Agreement with Hasten

The two agreements are expected to create significant financial and strategic synergies

15th December, 2025

China Gold Irradiation Introduces IBA’s sustainable X-ray irradiation technology

The Jianxing centre in East China will be the first CGI centre to install X-ray technology

11th December, 2025

Singleron's Matrix NEO Receives Class II Medical Device Approval for Automated Single Cell Analysis

Matrix NEO is the world's first automated single-cell analysis platform to achieve medical device clearance, marking a milestone in bringing single-cell sequencing from research laboratories into clinical practice

17th November, 2025

CoolMPS Brings a New Dimension to Sequencing

The collaboration enables MGI to leverage Swiss Rockets’ strong R&D capabilities and established presence in Europe and the U.S. to commercialise CoolMPS™

10th November, 2025